Bovalto Respi 3 suspension for injection for cattle 10ml (5 Dose)

Target species Cattle. Indications for use, specifying the target species For active immunisation of cattle in the absence of maternally derived antibodies against: - parainfluenza 3 virus, to reduce virus excretion due to infection - bovine respiratory syncytial virus, to reduce virus excretion due to infection - Mannheimia haemolytica serotype A1, to reduce clinical signs and lung lesions. Onset of immunity: 3 weeks Duration of immunity: 6 months Contraindications None. Special warnings for each target species Vaccinate healthy animals only. Special precautions for use in animals Safety and efficacy studies were performed in sero-negative calves. The efficacy of the vaccination has not been demonstrated in presence of antibodies. The level of antibody response may be reduced by the presence of maternal antibodies. In the presence of maternal antibodies, timing of initial vaccination of calves should be planned accordingly. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self- injection, seek medical advice immediately and show the package leaflet or the label to the physician. Adverse reactions (frequency and seriousness) A localised swelling may be very commonly observed at the injection site after vaccination. This swelling could reach up to 10 cm or more in diameter and may be associated with pain, and usually progressively reduces and disappears within 6 weeks after vaccination. A transient slight increase in body temperature may commonly appear which is higher after the second injection (1.5